Mannkind CORP Form 4 insider transactions

Steven B. Binder, a Director of Mannkind Corp, sold 39,051 shares of common stock on August 7, 2026 for $4.06 per share.

Christopher B Prentiss, Chief Financial Officer of Mannkind Corp, reported multiple transactions in common stock on July 15, 2026.

Dominic Marasco, Pres, Endocrine Business Unit of Mannkind Corp, reported a transaction in 3,623 shares of common stock on July 15, 2026.

Stuart A Tross, Chief People & Workpl Officer of Mannkind Corp, reported multiple transactions in common stock on July 15, 2026.

Michael Castagna, Chief Executive Officer and a Director of Mannkind Corp, reported multiple transactions in common stock on July 15, 2026.

Sanjay R Singh, EVP Technical Operations of Mannkind Corp, reported multiple transactions in common stock on July 15, 2026.

David Thomson, EVP Genl Counsel & Secretary of Mannkind Corp, sold 24,109 shares of common stock on July 15, 2026 for $4.05 per share.

Steven B. Binder, a Director of Mannkind Corp, sold 52,485 shares of common stock on July 15, 2026 for $4.06 per share.

Director Michael A. Friedman was granted 82,781 restricted stock units by MannKind Corporation on May 20, 2026.

Director Ronald J. Consiglio acquired 10,000 shares of MannKind Corporation common stock and received restricted stock unit grants.

Director Steven B. Binder was granted 82,781 restricted stock units by MannKind Corporation on May 20, 2026.

Director Jennifer Grancio was granted 82,781 restricted stock units by MannKind Corporation, while correcting prior reporting errors.

Director Anthony C. Hooper was granted 99,337 restricted stock units as part of his annual director compensation package.

Director James Shannon was granted restricted stock units in lieu of cash compensation for board service.

Chief People & Workplace Officer Stuart A. Tross acquired 33,898 shares of MannKind Corporation common stock.

Dominic Marasco, President of the Endocrine Business Unit at MannKind Corp, acquired 8,474 shares of common stock via the company's stock purchase plan.

Director Christine Mundkur was granted 82,781 restricted stock units by MannKind Corporation on May 20, 2026.

Director Sabrina Kay was granted 82,781 restricted stock units by MannKind Corporation on May 20, 2026.

Chief People & Workplace Officer Stuart A. Tross reported the withholding of 8,073 shares of MannKind common stock to satisfy tax obligations related to vested restricted stock units.

Director Steven B. Binder reported the sale of 16,940 shares of MannKind Corporation common stock following a tax-related share withholding.

CEO Michael Castagna disposed of 34,957 shares of MannKind Corporation to satisfy tax obligations related to vested restricted stock units.

EVP and General Counsel David Thomson reported the withholding of shares for taxes and a planned sale of MannKind common stock.

CEO Michael Castagna filed an amendment to revoke a previously reported transaction that was incorrectly attributed to him.

MannKind Corporation's Chief Financial Officer Christopher Prentiss disposed of 12,267 shares to satisfy tax requirements following the vesting of restricted stock units.

MannKind's Chief Financial Officer, Christopher B. Prentiss, was granted 221,000 performance-based restricted stock units and 217,000 employee stock options on March 23, 2026.

MannKind Corp's CEO, Michael Castagna, received significant equity awards including performance-based restricted stock units and employee stock options.

Sanjay R Singh, MannKind's EVP of Technical Operations, received 221,000 performance-based restricted stock units and 217,000 employee stock options.

MannKind Corp's Chief Medical Officer, Ajay Ahuja, was granted 221,000 performance-based restricted stock units and 217,000 employee stock options.

MannKind's Chief People & Workplace Officer, Stuart A. Tross, received grants of 221,000 performance-based restricted stock units and 217,000 employee stock options.

MannKind Corp's EVP, General Counsel & Secretary, David Thomson, was granted 221,000 performance-based restricted stock units and 217,000 employee stock options.